CONSERVATIVE THERAPY IN PATIENTS WITH BENIGN PROSTATE HYPERPLASIA – JUSTIFICATION FOR THE SIX-MONTH COURSE OF TREATMENT
Authors demonstrate the experience of medical treatment in 353 patients with Benign prostate hyperplasia, over the 2007–2012, with more than 5 years survey period. The therapy was cancelled after 6 months, at 51 (14,4 %) patients, on reaching complete medical and social rehabilitation. The combine therapy includes 0,5 mg dutasteride and 0,4 mg tamsulosine daily. Data analysis showed, that the short-course therapy indicates to the middle-age patients with Benign prostate hyperplasia, with 40-50cm3 prostate volume, moderate lower urinary tract symptoms and failing prostatitis. Sexual deterioration, showed at 7,8 % of patients, disappeared at 6 months. Considering the risk of progression, it seems to be important, these patients are under observation keeping, with the possibility of resuming treatment.